Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleWill savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis.AuthorsCurtis, Jeffrey R.; Xie, Fenglong; Kay, Jonathan; Kallich, Joel DPublicationArthritis Research & Therapy, 2019, Vol 21, Issue 1, p1ISSN1478-6354Publication typeArticleDOI10.1186/s13075-019-2022-8